Dipartimento di Scienze Biomediche, Università di Padova, Via Ugo Bassi 58/b, 35131, Padova, Italy.
Sorbonne Université, CNRS, IPCM, 4 Place Jussieu, 75005, Paris, France.
ChemMedChem. 2019 Oct 4;14(19):1717-1726. doi: 10.1002/cmdc.201900430. Epub 2019 Sep 24.
The ferrocenyl diphenol complexes 1,1-bis(4'-hydroxyphenyl)-2-ferrocenyl-but-1-ene (1) and 1,2-bis(4'-hydroxyphenyl)-1-ferrocenyl-but-1-ene [(Z)-2], which differ by the relative position of the two phenolic substituents, display dramatically different antiproliferative activities on cancer cells (1 is far more cytotoxic than 2). In this study, our goal was to discover the origin of this difference by comparing their reactivity and biological behaviour. In terms of common behaviour, we found that 1 and 2 are both efficient inhibitors of thioredoxin reductase (TrxR) in vitro after oxidation by a horseradish peroxidase/H O system. However, as 1 is only a moderate inhibitor of TrxR in MDA-MB-231 cells, TrxR is probably not the major target responsible for the cytotoxicity of 1. In terms of differences, we noted that 1 induced a significant redox imbalance characterised by lipid peroxidation and thiol oxidation, and a moderate decrease of the mitochondrial membrane potential in breast cancer cells, whereas 2 has almost no effect. These results underline the importance of the trans configuration in the ferrocenyl-double bond-phenol motif, which is present in 1 but is cis in (Z)-2.
二茂铁基二酚配合物 1,1-双(4'-羟基苯基)-2-二茂铁基-1-丁烯(1)和 1,2-双(4'-羟基苯基)-1-二茂铁基-1-丁烯[(Z)-2],它们的两个酚取代基的相对位置不同,对癌细胞表现出截然不同的抗增殖活性(1 的细胞毒性远强于 2)。在这项研究中,我们的目标是通过比较它们的反应性和生物学行为来发现这种差异的起源。在常见行为方面,我们发现 1 和 2 在辣根过氧化物酶/H O 系统氧化后都是体外硫氧还蛋白还原酶 (TrxR) 的有效抑制剂。然而,由于 1 仅在 MDA-MB-231 细胞中是 TrxR 的中度抑制剂,因此 TrxR 可能不是 1 细胞毒性的主要靶标。在差异方面,我们注意到 1 诱导了显著的氧化还原失衡,其特征为脂质过氧化和巯基氧化,以及线粒体膜电位的中度降低,而 2 几乎没有影响。这些结果强调了在 1 中存在的二茂铁基双键-酚基模体中的反式构型的重要性,而在 (Z)-2 中则为顺式构型。